Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Theranostics Market by, Product
6.1 Overview
6.2 Software and Services
6.3 Radiopharmaceuticals
6.4 IVD/Biomarker Screening
6.5 Diagnostic Imaging


7 Global Theranostics Market by, Application
7.1 Overview
7.2 Prostate Cancer
7.3 Bone Metastasis
7.4 Other Applications


8 Global Theranostics Market by, End User
8.1 Overview
8.2 Theranostics Centers
8.3 Research and Academic Centers
8.4 Hospitals and Cancer Care Centers


9 Global Theranostics Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa


10 Key Developments


11 Company Profiling
11.1 Bayer AG
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 GE Healthcare
11.3 Siemens Healthineers AG
11.4 Cardinal Health
11.5 Philips Healthcare
11.6 Canon Inc.
11.7 Curium
11.8 Lantheus
11.9 Northstar Medical Radioisotopes
11.10 Eckert & Ziegler
11.11 Pharmalogic
11.12 Eczacibasi-Monrol